ASP ISOTOPES INC (ASPI)

US00218A1051 - Common Stock

4.82  -0.22 (-4.37%)

After market: 4.85 +0.03 (+0.62%)

Fundamental Rating

2

ASPI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 83 industry peers in the Chemicals industry. ASPI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ASPI has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year ASPI has reported negative net income.
ASPI had a negative operating cash flow in the past year.

1.2 Ratios

ASPI has a worse Return On Assets (-35.77%) than 92.77% of its industry peers.
ASPI has a worse Return On Equity (-77.77%) than 89.16% of its industry peers.
Industry RankSector Rank
ROA -35.77%
ROE -77.77%
ROIC N/A
ROA(3y)-45.1%
ROA(5y)N/A
ROE(3y)-64.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ASPI's Gross Margin of 33.48% is fine compared to the rest of the industry. ASPI outperforms 65.06% of its industry peers.
ASPI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

ASPI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ASPI has been increased compared to 1 year ago.
Compared to 1 year ago, ASPI has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 3.81 indicates that ASPI is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 3.81, ASPI belongs to the best of the industry, outperforming 83.13% of the companies in the same industry.
ASPI has a Debt/Equity ratio of 0.87. This is a neutral value indicating ASPI is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.87, ASPI is not doing good in the industry: 63.86% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF N/A
Altman-Z 3.81
ROIC/WACCN/A
WACC9.21%

2.3 Liquidity

A Current Ratio of 7.55 indicates that ASPI has no problem at all paying its short term obligations.
With an excellent Current ratio value of 7.55, ASPI belongs to the best of the industry, outperforming 98.80% of the companies in the same industry.
ASPI has a Quick Ratio of 7.54. This indicates that ASPI is financially healthy and has no problem in meeting its short term obligations.
ASPI has a Quick ratio of 7.54. This is amongst the best in the industry. ASPI outperforms 98.80% of its industry peers.
Industry RankSector Rank
Current Ratio 7.55
Quick Ratio 7.54

1

3. Growth

3.1 Past

The earnings per share for ASPI have decreased strongly by -32.74% in the last year.
EPS 1Y (TTM)-32.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.59%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 27.07% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y47.92%
EPS Next 2Y29.9%
EPS Next 3Y28.56%
EPS Next 5Y27.07%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

ASPI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ASPI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

ASPI's earnings are expected to grow with 28.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.9%
EPS Next 3Y28.56%

0

5. Dividend

5.1 Amount

No dividends for ASPI!.
Industry RankSector Rank
Dividend Yield N/A

ASP ISOTOPES INC

NASDAQ:ASPI (12/27/2024, 8:04:09 PM)

After market: 4.85 +0.03 (+0.62%)

4.82

-0.22 (-4.37%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-19 2024-11-19/amc
Earnings (Next)N/A N/A
Inst Owners17.14%
Inst Owner Change155.39%
Ins Owners23.06%
Ins Owner Change18.7%
Market Cap344.10M
Analysts82.5
Price Target6.63 (37.55%)
Short Float %13.2%
Short Ratio1.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)44.44%
PT rev (3m)44.44%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-457.14%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-32.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 101.7
P/FCF N/A
P/OCF N/A
P/B 8.89
P/tB 9.77
EV/EBITDA N/A
EPS(TTM)-0.61
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS0.05
BVpS0.54
TBVpS0.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.77%
ROE -77.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.48%
FCFM N/A
ROA(3y)-45.1%
ROA(5y)N/A
ROE(3y)-64.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2050.22%
Cap/Sales 280.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.55
Quick Ratio 7.54
Altman-Z 3.81
F-Score5
WACC9.21%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.59%
EPS Next Y47.92%
EPS Next 2Y29.9%
EPS Next 3Y28.56%
EPS Next 5Y27.07%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-68.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-4.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-84.09%
OCF growth 3YN/A
OCF growth 5YN/A